Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2026-01-03 @ 8:39 PM
Study NCT ID:
NCT02015169
Status:
COMPLETED
Last Update Posted:
2018-01-17
First Post:
2013-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis
Sponsor:
Samsung Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07-09
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-17
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-17
First Submit QC Date:
None
Study First Post Date:
2013-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-15
Last Update Post Date:
2018-01-17
Last Update Post Date Type:
ACTUAL